RankAlpha logo
Back to Rankings

NBTX

NanobiotixF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Positive pivotal/clinical outcomes and a clear regulatory path drive rapid re-rating; partnerships or licensing could accelerate adoption.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Failed pivotal trial or negative clinical data
Momentum
7
Value
46
Sentiment
22
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $21.53 · Bull $32.30 · Bear $8.61Analysis 2026-01-16; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-26 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-16 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-10-26

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-26. Definitions

Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $55.68
Why
Momentum7 · Δ7d +3.0
Value46 · Δ7d +0.0
Sentiment22 · Δ7d -31.7
So what
Weak posture (Net Neutral). Prioritize risk control and patience.

Confirming evidence

  • • Value remains the lead driver in the composite, 7D delta +0.0.

Contradictions & invalidation

  • • Failed pivotal trial or negative clinical data
  • • Funding needs / equity dilution
  • • Failed readouts, prolonged regulatory uncertainty, or dilutive financing materially reduce equity value and push shares toward the low end of published targets.

Catalyst clock

2026-04-16

Analyst updates / consensus revisions

Lead driver: Value · See fundamentals
Momentum
7
8% active weight
Current posture
7d trendImproving
Δ7d
+3.0
Δ21d
-1.6
Value
46
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
0.0
Sentiment
22
45% active weight
Current posture
7d trendSoftening
Δ7d
-31.7
Δ21d
-17.4
Why this grade

Composite grade F. Momentum 6.6 / Value 46.5 / Sentiment 21.8

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-16. Scenario method

B+
Bull case
25%
Probability
Target price
$32.30
Analysis reference price unavailable
Analysis 2026-01-16 · RankAlpha Sentiment AI
Most likely
B
Base case
55%
Probability
Target price
$21.53
Analysis reference price unavailable
Analysis 2026-01-16 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$8.61
Analysis reference price unavailable
Analysis 2026-01-16 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$1.56B
Beta
0.18
Shares Out
50.8M
P/E (TTM) · Derived
-54.3
P/S (TTM)
89.51
P/FCF (TTM) · Derived
-35.57
Rev YoY
-39.5%
EPS YoY
+75.5%
Gross Margin
-35.7%
Op Margin
-49.1%
Net Debt
$50M
Current Ratio
1.09
As of 2026-10-26 • Updated nightlySource: Internal modelMethods & Data